The government of Assam has recently issued a new SOP that includes mandatory RT-PCR test on arrival for travelers coming from abroad, after the recent news of increasing cases of Omicron variant of COVID-19 in the country. The novel SOP i....

Korean bio-venture, 3bigs, has recently announced developing a big data platform for genome therapy and drug development in association with Amazon Web Services (AWS). As per credible sources, 3bigs will be working with Amazon Web Services....

Accolite Digital, an innovative, best-in-class digital transformation services provider, has recently announced acquiring Abyeti Technologies, the firm well known for building great enterprise software across multiple domains and technologi....

PVR NEST, the CSR (corporate social responsibility) division of PVR Ltd., and Deakin University, Australia, one of the most advanced international education providers, have cooperatively unveiled 'You for Youth' – a digital ca....

Cartula Health India, India’s foremost telemedicine startup which intends to revolutionize healthcare across India, has recently announced an innovative service sponsored by Medway Technologies - an AI-powered platform that links heal....

Telstra, an Australian telecommunications company, has reportedly started testing the new technology in the scam messaging space. As per reliable sources, the new technology will block scam SMS messages as the number of scams received by th....

The news of a new strain of coronavirus termed Omicron is gaining attention worldwide. The new coronavirus variant has become a hot topic of discussion across the world. Governors around the United States have recently assured Americans th....

LetsTransport, a tech-logistics company based in Bengaluru, has collaborated with integrated charging infrastructure provider EVRE to cater to the parking and charging infra needs of its 1,000 EV fleet. As a part of the deal, EVRE will bui....

Soaring coronavirus cases have broken past records in Europe, once again putting the continent at the epicenter of the pandemic. As a result of unprecedented events, health experts have been stressing upon the need to widen the use of boos....

GlycoMimetics, Inc., a firm that develops molecule drugs, has recently announced that biotech company Apollomics has dosed first patient in China in a Phase 3 clinical trial of its new relapsed or refractory acute myeloid leukemia (AML) dru....